Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06613568 · ClinicalTrials.gov registry record · NA

Moda-flx Hemodialysis System™ Under Professional Care Settings by Trained Individuals and At Home by Participants

A NA study of End-Stage Kidney Disease, sponsored by Diality.

Recruiting
Registry status
NA
Development phase
50
Enrollment target
4
Study locations

NCT06613568 is a NA study of End-Stage Kidney Disease that is actively recruiting participants, run by Diality. The registered enrollment target is 50 participants, below the 463-participant average among 20 other End-Stage Kidney Disease trials with a reported enrollment target (89% lower). The trial reports 4 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06613568, a NA study of End-Stage Kidney Disease, is actively recruiting participants, sponsored by Diality.

RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target
4
Study locations

Study Summary

The purpose of this study is to evaluate the safety and efficacy of the Moda-flx Hemodialysis System™ when used Under Professional Care Settings by trained individuals and At Home by trained Participants and Care Partners

Conditions Studied

End-Stage Kidney Disease

Interventions

  • DEVICE Moda-flx Hemodialysis System™

Study Locations (4)

California

  • North America Research Institute - San Dimas

Tennessee

  • Nephrology Associates of Knoxville - Knoxville

Texas

  • aQua Research Institute, LLC - Houston

Washington

  • University of Washington - Seattle

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2025-10-06
Est. Completion 2027-09
Phase NA

Sponsor

Diality

2 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06613568

The ClinicalTrials.gov registry entry for NCT06613568 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 463-participant average among 20 other End-Stage Kidney Disease trials with a reported enrollment target (89% lower). The listed sponsor is Diality, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with End-Stage Kidney Disease appearing as the primary indexed condition, and to 1 intervention - of which Moda-flx Hemodialysis System™ is the first listed.

NCT06613568 reports 4 study locations spanning 4 distinct geographic areas - top geographies include California, Tennessee, Texas.

Frequently Asked Questions

What is clinical trial NCT06613568 about?

NCT06613568 is a clinical study titled "Moda-flx Hemodialysis System™ Under Professional Care Settings by Trained Individuals and At Home by Participants". The purpose of this study is to evaluate the safety and efficacy of the Moda-flx Hemodialysis System™ when used Under Professional Care Settings by trained individuals and At Home by trained Participants and Care Partners

What is the current status of trial NCT06613568?

This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2025-10-06. Estimated completion is 2027-09.

What conditions does trial NCT06613568 study?

This clinical trial studies the following conditions: End-Stage Kidney Disease.

What interventions are being tested in trial NCT06613568?

The interventions under investigation include: Moda-flx Hemodialysis System™ (DEVICE).

Who is sponsoring clinical trial NCT06613568?

This trial is sponsored by Diality, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06613568 being conducted?

This trial has 4 study locations across California, Tennessee, Texas, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for End-Stage Kidney Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

End-Stage Kidney Disease

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.